Results 151 to 160 of about 1,693 (197)
Some of the next articles are maybe not open access.

Treatment of Preterm Labor with the Oxytocin Antagonist Atosiban

American Journal of Perinatology, 1996
The purpose of this study was to describe the course of preterm labor in patients receiving a standard intravenous infusion of the oxytocin antagonist atosiban. An open-labeled, non-randomized study was conducted at 4 sites. Successful tocolysis was defined as delay of delivery larger than 48 hours from starting atosiban and no need for an alternate ...
T Murphy Goodwin
exaly   +3 more sources

The use of atosiban and ritodrine in external cephalic version

Acta Obstetricia et Gynecologica Scandinavica, 2007
AbstractObjective. To compare the efficacy of atosiban and ritodrine as tocolytic agents for successful external cephalic version (ECV). Factors affecting the success of ECV, as well as maternal and perinatal outcomes are reviewed. Method. A retrospective review of women who underwent ECV with either atosiban (2004) or ritodrine (2002).
Iosifina, Stergiotou   +2 more
openaire   +2 more sources

Atosiban

Reactions Weekly, 2022
openaire   +1 more source

Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

Obstetrics and gynecology, 1996
To evaluate the minimal effective dose regimen of the oxytocin antagonist atosiban in the treatment of acute preterm labor and the effect of a bolus on uterine activity within the first 2 hours compared with no bolus and the same infusion rate.A randomized, double-blind (except the ritodrine group), parallel group, multicenter study compared four ...
T M, Goodwin   +3 more
openaire   +1 more source

Atosiban/misoprostol

Reactions Weekly, 2022
openaire   +1 more source

Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.

American journal of obstetrics and gynecology, 2000
Patients admitted with an acute episode of preterm labor who respond to early intravenously administered tocolysis remain at risk of having subsequent episodes of preterm labor and preterm delivery. Several pharmacologic agents have been used in an attempt to reduce subsequent episodes of preterm labor, and all are associated with significant side ...
G J, Valenzuela   +11 more
openaire   +1 more source

Atosiban

Reactions Weekly, 2017
openaire   +1 more source

atosiban

2009
Guillaume Chevrel, Virginie Dessus
openaire   +1 more source

Home - About - Disclaimer - Privacy